JANX vs NVR · rev $10.3M vs P/E 15, rev $4.21B
Janux Therapeutics Inc (JANX) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
JANX currently screens at market cap $1.49B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the JANX and NVR stock pages for the full models.
Not investment advice.